WO2002072630A3 - Nucleic acid-associated proteins - Google Patents

Nucleic acid-associated proteins Download PDF

Info

Publication number
WO2002072630A3
WO2002072630A3 PCT/US2002/003844 US0203844W WO02072630A3 WO 2002072630 A3 WO2002072630 A3 WO 2002072630A3 US 0203844 W US0203844 W US 0203844W WO 02072630 A3 WO02072630 A3 WO 02072630A3
Authority
WO
WIPO (PCT)
Prior art keywords
naap
nucleic acid
associated proteins
provides
polynucleotides
Prior art date
Application number
PCT/US2002/003844
Other languages
French (fr)
Other versions
WO2002072630A2 (en
Inventor
Michael Thornton
April J A Hafalia
Dyung Aina M Lu
Chandra Arvizu
Anita Swarnakar
Yan Lu
Bridget A Warren
Mariah R Baughn
Y Tom Tang
Ernestine A Lee
Monique G Yao
Jayalaxmi Ramkumar
Farrah A Khan
Ameena R Gandhi
Li Ding
Henry Yue
Kimberly J Gietzen
Narinder K Chawla
Kavitha Thangavelu
Vicki S Elliott
Joseph P Marquis
Original Assignee
Incyte Genomics Inc
Michael Thornton
April J A Hafalia
Dyung Aina M Lu
Chandra Arvizu
Anita Swarnakar
Yan Lu
Bridget A Warren
Mariah R Baughn
Y Tom Tang
Ernestine A Lee
Monique G Yao
Jayalaxmi Ramkumar
Farrah A Khan
Ameena R Gandhi
Li Ding
Henry Yue
Kimberly J Gietzen
Narinder K Chawla
Kavitha Thangavelu
Vicki S Elliott
Joseph P Marquis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Michael Thornton, April J A Hafalia, Dyung Aina M Lu, Chandra Arvizu, Anita Swarnakar, Yan Lu, Bridget A Warren, Mariah R Baughn, Y Tom Tang, Ernestine A Lee, Monique G Yao, Jayalaxmi Ramkumar, Farrah A Khan, Ameena R Gandhi, Li Ding, Henry Yue, Kimberly J Gietzen, Narinder K Chawla, Kavitha Thangavelu, Vicki S Elliott, Joseph P Marquis filed Critical Incyte Genomics Inc
Priority to EP02726569A priority Critical patent/EP1430130A2/en
Priority to US10/467,397 priority patent/US20040137448A1/en
Priority to JP2002571543A priority patent/JP2005504509A/en
Priority to AU2002256993A priority patent/AU2002256993A1/en
Priority to CA002437756A priority patent/CA2437756A1/en
Publication of WO2002072630A2 publication Critical patent/WO2002072630A2/en
Publication of WO2002072630A3 publication Critical patent/WO2002072630A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

The invention provides human nucleic acis-associated protein (NAAP) and polynucleotides which identify and encode NAAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.
PCT/US2002/003844 2001-02-09 2002-02-07 Nucleic acid-associated proteins WO2002072630A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP02726569A EP1430130A2 (en) 2001-02-09 2002-02-07 Nucleic acid-associated proteins
US10/467,397 US20040137448A1 (en) 2002-02-07 2002-02-07 Nucleic acid-associated proteins
JP2002571543A JP2005504509A (en) 2001-02-09 2002-02-07 Nucleic acid-related proteins
AU2002256993A AU2002256993A1 (en) 2001-02-09 2002-02-07 Nucleic acid-associated proteins
CA002437756A CA2437756A1 (en) 2001-02-09 2002-02-07 Nucleic acid-associated proteins

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US26811801P 2001-02-09 2001-02-09
US60/268,118 2001-02-09
US27096301P 2001-02-21 2001-02-21
US60/270,963 2001-02-21
US27085801P 2001-02-22 2001-02-22
US60/270,858 2001-02-22
US27119401P 2001-02-23 2001-02-23
US60/271,194 2001-02-23
US27407101P 2001-03-07 2001-03-07
US60/274,071 2001-03-07
US28349601P 2001-04-12 2001-04-12
US60/283,496 2001-04-12
US34465001P 2001-11-09 2001-11-09
US60/344,650 2001-11-09

Publications (2)

Publication Number Publication Date
WO2002072630A2 WO2002072630A2 (en) 2002-09-19
WO2002072630A3 true WO2002072630A3 (en) 2004-04-29

Family

ID=27569530

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/003844 WO2002072630A2 (en) 2001-02-09 2002-02-07 Nucleic acid-associated proteins

Country Status (5)

Country Link
EP (1) EP1430130A2 (en)
JP (1) JP2005504509A (en)
AU (1) AU2002256993A1 (en)
CA (1) CA2437756A1 (en)
WO (1) WO2002072630A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041643B2 (en) * 2001-01-31 2006-05-09 Millennium Pharmaceuticals, Inc. Molecules of the PYRIN/NBS/LRR protein family and uses thereof
WO2002064797A2 (en) * 2001-02-16 2002-08-22 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Mitochondrial topoisomerase i

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031538A1 (en) * 1994-05-18 1995-11-23 Human Genome Sciences, Inc. Human dna topoisomerase i-alpha
US5723311A (en) * 1995-06-02 1998-03-03 Human Genome Sciences, Inc. Human DNA topoisomerase I α

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031538A1 (en) * 1994-05-18 1995-11-23 Human Genome Sciences, Inc. Human dna topoisomerase i-alpha
US5723311A (en) * 1995-06-02 1998-03-03 Human Genome Sciences, Inc. Human DNA topoisomerase I α

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHANG HONGLIANG ET AL: "Human mitochondrial topoisomerase I.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 98, no. 19, 11 September 2001 (2001-09-11), September 11, 2001, pages 10608 - 10613, XP002229078, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
AU2002256993A1 (en) 2002-09-24
EP1430130A2 (en) 2004-06-23
CA2437756A1 (en) 2002-09-19
JP2005504509A (en) 2005-02-17
WO2002072630A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2003094848A3 (en) Nucleic acid-associated proteins
WO2002072794A3 (en) Immunoglobulin superfamily proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2001096546A3 (en) Protein phosphatases
WO2003054219A3 (en) Nucleic acid-associated proteins
WO2002010363A3 (en) Protein phosphatases
WO2002086069A3 (en) Secreted proteins
WO2002070669A3 (en) Secreted proteins
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2001085942A3 (en) Cytoskeleton-associated proteins
WO2003038052A3 (en) Nucleic acid-associated proteins
WO2002053719A3 (en) Cytoskeleton-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2002024924A3 (en) Protein phosphatases
WO2001083524A3 (en) Rna metabolism proteins
WO2003010329A3 (en) Nucleic acid-associated proteins
WO2002099115A3 (en) Nucleic acid-associated proteins
WO2002079441A3 (en) Secreted proteins
WO2003016549A3 (en) Nucleic-acid associated proteins
WO2003025542A3 (en) Immune response associated proteins
WO2000060082A3 (en) Vesicle associated proteins
WO2003006618A3 (en) Nucleic acid-associated proteins
WO2002072630A3 (en) Nucleic acid-associated proteins
WO2002040671A3 (en) Immunoglobulin superfamily proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2437756

Country of ref document: CA

Ref document number: 10467397

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002571543

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002726569

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002726569

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002726569

Country of ref document: EP